Target intelligence / Profile preview

Solute carrier organic anion transporter family member 1B3-1B7 (SLCO1B3-SLCO1B7)

Target
SLCO1B3-SLCO1B7
Molecular classification
Transporter, Organic anion transporter, Solute carrier protein
01

Overview

Solute carrier organic anion transporter family member 1B3-1B7 (SLCO1B3-SLCO1B7) is a fusion protein encoded by a naturally occurring readthrough transcript between the SLCO1B3 and SLCO1B7 genes on chromosome 12[1][2][3][6]. It is classified as a member of the organic anion transporting polypeptide (OATP) family and is predominantly expressed in the smooth endoplasmic reticulum of hepatocytes[2]. The transporter facilitates the sodium-independent uptake of organic anions, including steroid conjugates (such as dehydroepiandrosterone sulfate [DHEAS] and 17-beta-glucuronosyl estradiol) and bile acids, into the smooth endoplasmic reticulum for further metabolism[1][2]. Genetic variants in the SLCO1B7-encoded portion of this protein can reduce or abolish transport activity, which may have pharmacogenetic implications and could contribute to disorders such as Rotor-type hyperbilirubinemia and potentially variable drug response[1][2].

Other names
OATP1B3-1B7LST-3TM12SLCO1B3-SLCO1B7 readthrough transcript proteinOrganic anion transporting polypeptide 1B3-1B7Liver specific transporter-3 transmembrane 12Solute carrier organic anion transporter family member 1B3-1B7
02

Mechanism of action

Mediates Na(+)-independent uptake of organic anions from cytosol into smooth endoplasmic reticulum for metabolism. Affects intracellular drug distribution and metabolism.

03

Biological functions

Cellular uptake of organic anionsMetabolism of conjugated steroids (e.g., 17-beta-glucuronosyl estradiol, dehydroepiandrosterone 3-sulfate)Bile acid transport (e.g., taurocholate, lithocholate)Regulating access/exit of drugs to the smooth endoplasmic reticulum lumen
04

Disease associations

Hyperbilirubinemia, Rotor typePotential relevance in pharmacogenomics (drug response variation)
05

Safety considerations

Genetic variants can alter transporter function, potentially influencing susceptibility to metabolic disorders (e.g., hyperbilirubinemia)Polymorphisms can affect drug response, raising concerns in personalized medicine
06

Interacting drugs

Dehydroepiandrosterone sulfate (DHEAS)

2 more in the full profile.

07

Biomarkers

Genetic variants affecting transporter function (potentially as pharmacogenomic markers for drug metabolism/response)

Beyond the preview

Go deeper on Solute carrier organic anion transporter family member 1B3-1B7 (SLCO1B3-SLCO1B7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier organic anion transporter family member 1B3-1B7 (SLCO1B3-SLCO1B7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call